WHO ICTRP trial
Picosecond Laser combined with a Cream Formulation Containing Levorotatory…
ChiCTR2100042939 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100042939 |
|---|---|
| Public title | Picosecond Laser combined with a Cream Formulation Containing Levorotatory Vitamin C 10% and Arbutin 4% for Treatment of Melasma |
| Scientific title | Picosecond Laser combined with a Cream Formulation Containing Levorotatory Vitamin C 10% and Arbutin 4% for Treatment of Melasma |
| Primary sponsor | Beijing Friendship Hospital Affiliated to Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | melasma |
| Interventions | control group:755nm picosecond laser;experimental group:755nm picosecond laser combined with a cream formulation containing levorotatory vitamin C and arbutin |
| Registration date | Feb 1, 2021 |
| Target size | control group:25;experimental group:25 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: